.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Baxter
Queensland Health
Farmers Insurance
Fish and Richardson
Chinese Patent Office
Cerilliant
US Army
Mallinckrodt
Cipla

Generated: June 26, 2017

DrugPatentWatch Database Preview

Idarubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for idarubicin hydrochloride and what is the scope of idarubicin hydrochloride patent protection?

Idarubicin hydrochloride
is the generic ingredient in four branded drugs marketed by Pharmacia And Upjohn, Teva Pharms Usa, Teva Parenteral, Fresenius Kabi Usa, Mylan Labs Ltd, West-ward Pharms Int, and Sandoz, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for idarubicin hydrochloride. Six suppliers are listed for this compound.

Summary for Generic Name: idarubicin hydrochloride

Tradenames:4
Patents:1
Applicants:7
NDAs:9
Drug Master File Entries: see list6
Suppliers / Packagers: see list6
Bulk Api Vendors: see list58
Clinical Trials: see list2,429
Patent Applications: see list7,388
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:idarubicin hydrochloride at DailyMed

Pharmacology for Ingredient: idarubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
IDARUBICIN HYDROCHLORIDE
idarubicin hydrochloride
INJECTABLE;INJECTION065275-001Dec 14, 2006APRXNoNo► Subscribe► Subscribe
Teva Parenteral
IDARUBICIN HYDROCHLORIDE
idarubicin hydrochloride
INJECTABLE;INJECTION065037-003May 1, 2002DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
IDAMYCIN PFS
idarubicin hydrochloride
INJECTABLE;INJECTION050734-001Feb 17, 1997APRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
IDAMYCIN
idarubicin hydrochloride
INJECTABLE;INJECTION050661-003Apr 25, 1995DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
IDARUBICIN HYDROCHLORIDE
idarubicin hydrochloride
INJECTABLE;INJECTION065440-001Aug 4, 2009APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Mallinckrodt
Merck
Farmers Insurance
Chubb
Novartis
McKinsey
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot